2022
DOI: 10.3389/fonc.2022.918580
|View full text |Cite
|
Sign up to set email alerts
|

Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies

Abstract: ObjectiveDigital pathology with whole-slide imaging (WSI) has many potential clinical and non-clinical applications. In the past two decades, despite significant advances in WSI technology adoption remains slow for primary diagnosis. The aim of this study was to identify common pitfalls of WSI reported in validation studies and offer measures to overcome these challenges.MethodsA systematic search was conducted in the electronic databases Pubmed-MEDLINE and Embase. Inclusion criteria were all validation studie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 45 publications
0
5
0
Order By: Relevance
“…WSI acquisition problems are well‐known to hinder the widespread use of digital cytopathology. Whilst scan failure is a recognised technical issue for histology specimens, 20 this is particularly true for cytology smears because they contain three‐dimensional cellular groups and often have obscuring material. Z ‐stacking (i.e.…”
Section: Discussionmentioning
confidence: 99%
“…WSI acquisition problems are well‐known to hinder the widespread use of digital cytopathology. Whilst scan failure is a recognised technical issue for histology specimens, 20 this is particularly true for cytology smears because they contain three‐dimensional cellular groups and often have obscuring material. Z ‐stacking (i.e.…”
Section: Discussionmentioning
confidence: 99%
“…Further publications are necessary to support this transformation, specifically clinical validation studies. 45 …”
Section: Discussionmentioning
confidence: 99%
“…In this respect, the Bioresource Research Impact Factor/Framework (BRIF) initiative was proposed for transparency and to promote the responsible and effective use of biomaterials (Cambon-Thomsen, 2003). Another point that is worth mentioning is related to the integration of artificial intelligence (AI) and machine learning into modern biobanks (Kinkorová and Topolčan, 2020;Eccher et al, 2021;Narita et al, 2021;Rizzo et al, 2022). This would allow for the integration of a digitalized database with digital pathology and high throughput molecular data, potentially representing a quantum leap in biobanking.…”
Section: Discussionmentioning
confidence: 99%